Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 25/05/19941 min de lecture
Solvay Animal Health, Inc., et al.; Withdrawal of Approval of NADA's
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADA's). One NADA is held by Solvay Animal Health, Inc., and provides for the use of a sulfaquinoxaline soluble powder. The other NADA is held by Pharmachem Corp. and provides for the use of a dextran injection. The sponsors requested withdrawal of approval of the NADA's because they no longer manufacture or distribute the products.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →